Genesiscare has openly stated that they are in the works to secure a partnership with a US provider, this will open up opportunities to potentially double their reach, which would likely be reflected in their patients treated.
As they treat 350,000 patients per year, assuming this would also double I can hardly see how this news has been turned into a "pump and dump" - other than those who are caught up on not being offered the 18c issue, presuming they were being sold to exec's friends and now thinking that it's a pump and dump (far fetched hey?)
Holders - rest easy. We have had a lot of good news as of late from NOX!
*DYOR *I currently hold shares in NOX
NOX Price at posting:
28.0¢ Sentiment: Hold Disclosure: Held
